Cleared Special

K041656 - MODIFICATION TO DEPUY 1 GENTAMICIN BONE CEMENT AND SMARTSET GMV ENDURANCE GENTAMICIN BONE CEMENT (FDA 510(k) Clearance)

Jul 2004
Decision
13d
Days
Class 2
Risk

K041656 is an FDA 510(k) clearance for the MODIFICATION TO DEPUY 1 GENTAMICIN BONE CEMENT AND SMARTSET GMV ENDURANCE GENTAMICIN BONE CEMENT. This device is classified as a Bone Cement (Class II - Special Controls, product code LOD).

Submitted by DePuy Orthopaedics, Inc. (Warsaw, US). The FDA issued a Cleared decision on July 1, 2004, 13 days after receiving the submission on June 18, 2004.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3027.

Submission Details

510(k) Number K041656 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 18, 2004
Decision Date July 01, 2004
Days to Decision 13 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code LOD - Bone Cement
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3027